New insights into the molecular phenotype of eccentric hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 2, 2010, Pages 153-156

  Sciarretta, Sebastiano ^a   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; CARDIOTROPHIN 1; CONTRACTILE PROTEIN; CYTOSKELETON PROTEIN; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 130; INTEGRIN; ION CHANNEL; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE SHP 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

AORTA STENOSIS; CELL SIZE; EDITORIAL; ENZYME ACTIVATION; ENZYME INHIBITION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RHYTHM; HEART STRESS; HEART VALVE REGURGITATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERVOLEMIA; MUSCLE FIBRIL; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SARCOMERE; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CARDIOMEGALY; CYTOKINES; HUMANS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 77953718614     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.03.018     Document Type: Editorial

References (36)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006 Aug, 7(8):589-600.
2. Opie L.H., Commerford P.J., Gersh B.J., Pfeffer M.A. Controversies in ventricular remodelling. Lancet 2006 Jan 28, 367(9507):356-367.
3. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975 Jul, 56(1):56-64.
4. Matsuo T., Carabello B.A., Nagatomo Y., Koide M., Hamawaki M., Zile M.R., et al. Mechanisms of cardiac hypertrophy in canine volume overload. Am J Physiol 1998 Jul, 275(1 Pt 2):H65-H74.
5. Nagatomo Y., Carabello B.A., Hamawaki M., Nemoto S., Matsuo T., McDermott P.J. Translational mechanisms accelerate the rate of protein synthesis during canine pressure-overload hypertrophy. Am J Physiol 1999 Dec, 277(6 Pt 2):H2176-H2184.
6. Imamura T, McDermott PJ, Kent RL, Nagatsu M, Gt Cooper, Carabello BA. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res Sep 1994, 75(3):418-425.
7. Moalic J.M., Bercovici J., Swynghedauw B. Protein synthesis during systolic and diastolic cardiac overloading in rats: a comparative study. Cardiovasc Res 1981 Sep, 15(9):515-521.
8. Dool J.S., Mak A.S., Friberg P., Wahlander H., Hawrylechko A., Adams M.A. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy. Acta Physiol Scand 1995 Dec, 155(4):396-404.
9. Calderone A., Takahashi N., Izzo N.J., Thaik C.M., Colucci W.S. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995 Nov 1, 92(9):2385-2390.
10. Wollert K.C., Taga T., Saito M., Narazaki M., Kishimoto T., Glembotski C.C., et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996 Apr 19, 271(16):9535-9545.
11. Nakaoka Y., Nishida K., Fujio Y., Izumi M., Terai K., Oshima Y., et al. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ Res 2003 Aug 8, 93(3):221-229.
12. Suurmeijer A.J., Clement S., Francesconi A., Bocchi L., Angelini A., Van Veldhuisen D.J., et al. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol. 2003 Mar, 199(3):387-397.
13. Hewett T.E., Grupp I.L., Grupp G., Robbins J. alpha-Skeletal actin is associated with increased contractility in the mouse heart. Circ Res 1994 Apr, 74(4):740-746.
14. Berni R., Savi M., Bocchi L., Delucchi F., Musso E., Chaponnier C., et al. Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. Am J Physiol Heart Circ Physiol. 2009 May, 296(5):H1625-H1632.
15. Pemberton C.J., Raudsepp S.D., Yandle T.G., Cameron V.A., Richards A.M. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res 2005 Oct 1, 68(1):109-117.
16. Wang F., Seta Y., Baumgarten G., Engel D.J., Sivasubramanian N., Mann D.L. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circulation. 2001 Mar 6, 103(9):1296-1302.
17. Serneri G.G., Boddi M., Cecioni I., Vanni S., Coppo M., Papa M.L., et al. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001 May 11, 88(9):961-968.
18. Simpson D.G., Majeski M., Borg T.K., Terracio L. Regulation of cardiac myocyte protein turnover and myofibrillar structure in vitro by specific directions of stretch. Circ Res 1999 Nov 12, 85(10):e59-e69.
19. Yamamoto K., Dang Q.N., Maeda Y., Huang H., Kelly R.A., Lee R.T. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation. 2001 Mar 13, 103(10):1459-1464.
20. Sabri A., Rafiq K., Seqqat R., Kolpakov M.A., Dillon R., Dell'italia L.J. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog. Circ Res 2008 May 9, 102(9):1127-1136.
21. Sopontammarak S., Aliharoob A., Ocampo C., Arcilla R.A., Gupta M.P., Gupta M. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy. Cell Biochem Biophys 2005, 43(1):61-76.
22. Nakaoka Y., Shioyama W., Kunimoto S., Arita Y., Higuchi K., Yamamoto K., Fujio Y., Nishida K., Kuroda T., Hirota H., Yamauchi-Takihara K., Hirano T., Komuro I., Mochizuki N. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene. Journal of Molecular and Cellular Cardiology 2010, 49(2):157-164.
23. Kobayashi N., Horinaka S., Mita S., Nakano S., Honda T., Yoshida K., et al. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts. Cardiovasc Res 2002 Sep, 55(4):757-767.
24. Aikawa R., Komuro I., Nagai R., Yazaki Y. Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes. Mol Cell Biochem 2000 Sep, 212(1-2):177-182.
25. Wei L., Zhou W., Croissant J.D., Johansen F.E., Prywes R., Balasubramanyam A., et al. RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J Biol Chem. 1998 Nov 13, 273(46):30287-30294.
26. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., Olson E.N. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001 Jun 1, 20(11):2757-2767.
27. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross J., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999 Apr 16, 97(2):189-198.
28. Kontaridis M.I., Yang W., Bence K.K., Cullen D., Wang B., Bodyak N., et al. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation. 2008 Mar 18, 117(11):1423-1435.
29. Tsutsui H., Tagawa H., Kent R.L., McCollam P.L., Ishihara K., Nagatsu M., et al. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation. 1994 Jul, 90(1):533-555.
30. Nagatomo Y., Carabello B.A., Coker M.L., McDermott P.J., Nemoto S., Hamawaki M., et al. Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol. 2000 Jan, 278(1):H151-H161.
31. De Acetis M., Notte A., Accornero F., Selvetella G., Brancaccio M., Vecchione C., et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res 2005 May 27, 96(10):1087-1094.
32. Lu H., Fedak P.W., Dai X., Du C., Zhou Y.Q., Henkelman M., et al. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation. 2006 Nov 21, 114(21):2271-2279.
33. Takahashi N., Saito Y., Kuwahara K., Harada M., Tanimoto K., Nakagawa Y., et al. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol. 2005 Jan, 38(1):185-192.
34. Wada H., Ivester C.T., Carabello B.A., Cooper G., McDermott P.J. Translational initiation factor eIF-4E. A link between cardiac load and protein synthesis. J Biol Chem. 1996 Apr 5, 271(14):8359-8364.
35. Kato T., Sano M., Miyoshi S., Sato T., Hakuno D., Ishida H., et al. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats. Circ Res 2000 Nov 10, 87(10):937-945.
36. DiMichele L.A., Doherty J.T., Rojas M., Beggs H.E., Reichardt L.F., Mack C.P., et al. Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy. Circ Res 2006 Sep 15, 99(6):636-645.